Dermatology and Venereology

Uzm. Dr. Gürbüz Yıldırım

Doctor and researcher Bağcılar Eğitim ve Araştırma Hastanesi İstanbul

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyDermatology and Venereologysaglik.gov.trFrom source
  • InstitutionBağcılar Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Publications9 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0003-4195-1825ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://bagcilareah.saglik.gov.tr/TR-1478292/doktorlarimiz.html#gurbuz-yildirimsaglik.gov.tr

Scientific work

Publications

9 publications
  1. Evaluation of clinical and follow-up data in patients with mycosis fungoides: a 10-year single-centre experience

    Archives of Dermatological Research, 2026

    DOI 10.1007/s00403-026-04943-7 Source: ORCID

  2. A Retrospective Analysis of Patients Diagnosed with Morphea (Localized Scleroderma) in Terms of Age, Gender, Clinical Subtype, and Anatomical Involvement

    Cerrahpaşa Medical Journal, 2026

    DOI 10.5152/cjm.2026.25086 Open-access full textSource: ORCID

  3. Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study

    Anais Brasileiros de Dermatologia, 2026

    DOI 10.1016/j.abd.2026.501353 PMID 42025118 Open-access full textSource: ORCID

  4. Impact of Nail Psoriasis on Quality of Life: A Turkish Validation Study of NPQ-10 and NAPPA

    Skin Appendage Disorders, 2026

    DOI 10.1159/000550467 PMID 41704948 Open-access full textSource: ORCID

  5. Clinical and Demographic Characteristics of Pediatric Patients With Psoriasis: Age‐Related Variations and Remission Predictors

    Pediatric Dermatology, 2026

    DOI 10.1111/pde.16043 PMID 41611250 Source: ORCID

  6. Real-world single-centre experience of bimekizumab in patients with psoriasis: a 16-week retrospective observational study

    Skin Health and Disease, 2026

    DOI 10.1093/skinhd/vzag060 PMID 42540044 Open-access full textSource: OpenAlex

  7. Upadacitinib for refractory prurigo nodularis: a two-centre real-world cohort using step-up dosing

    Research Square, 2026

    DOI 10.21203/rs.3.rs-11206161/v1 Open-access full textSource: OpenAlex

  8. A Rare Case of Pachyonychia Congenita and the Need for Awareness

    Balkan Medical Journal, 2024

    DOI 10.4274/balkanmedj.galenos.2024.2024-2-23 PMID 38619174 Open-access full textSource: ORCID

  9. Güncel Mikozis Fungoides

    Akademisyen Kitabevi eBooks, 2023

    DOI 10.37609/akya.2496 Open-access full textSource: OpenAlex